Get the Weekly Intelligence Brief — top committee picks every Sunday.
NASDAQ · STOCK

Sabra Health Care REIT

SBRA Real Estate Unknown Updated July 20, 2026
$22.03
52W $17.17 – $21.28
58/100
31.1
0.63
Explore SBRA Further
📈 Rating History 💰 Earnings 📰 Recent Events 🔄 What Changed 📖 Thesis Evolution 🔍 Similar Stocks
AI Committee Verdict
Watch
Conviction: Contested · 50% agreement · 6 analysts
+0.1%
-4.5%
0.02:1
Contested
Is SBRA Bullish or Bearish?
Mixed. Innellis AI committee rates Sabra Health Care REIT (SBRA) Watch with a composite score of 58/100 , based on 6 analysts with 50% agreement. Last updated July 20, 2026.
Executive Summary
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull & Bear Case
Bull Case
  • Positive MACD histogram signals bullish momentum.
  • Daily trend: uptrend.
  • Weekly trend: uptrend.
  • Daily and weekly trends are both bullish — multi-timeframe alignment, highest confidence.
  • Daily volatility (ATR%) above ~3% is treated as elevated risk.
Bear Case
  • Risk/reward is unfavorable: 4.5% downside vs 0.1% upside.
Price History (6M)
AI Investment Committee
Committee Consensus As of July 20, 2026
Overall Committee Score
58/100
Agreement
50%
Analysts
6
Conviction
Contested
Value Analyst neutral
48 / 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
+ Dividend yield of 6.0% pays you to wait
− P/E of 32.2 is moderate-to-rich
Growth Analyst neutral
57 / 100 · High confidence
Moderate growth -- present but not remarkable
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
− 3 consecutive earnings misses -- execution concerns
Technical Analyst bullish
61 / 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
Macro Analyst bullish
70 / 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst bullish
67 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.29 across 7 articles, 14d)
Portfolio Manager neutral
45 / 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2975.52)
Open Full Terminal →
Investment Thesis Evolution

Committee score moved marginally from 57.9 to 57.9.

Analyst-level changes:
  • Portfolio Manager: +1 bearish signal(s).
  • Value Analyst: +1 bearish signal(s).

Comparing 2026-07-19 to 2026-07-20 (1 day apart).

Technical Analysis
RSI (14)
58.6
Neutral
MACD Histogram
0.057
Bullish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Mixed
Support
$19.09
Resistance
$20.02
Bollinger %B
0.70
Inside Bands
Price vs Moving Averages
EMA 9
$19.87 Above
EMA 21
$19.66 Above
EMA 50
$19.63 Above
EMA 200
$19.38 Above
Fundamental Analysis
Valuation
44
Growth
32
Profitability
0
Financial Health
88
Cash Flow
38
Valuation
P/E Ratio 31.1×
P/B Ratio 1.81×
PEG Ratio 4.66
Dividend Yield 0.06%
52W High $21.28
52W Low $17.17
Quality & Growth
ROE 5.5%
ROA 2.8%
Gross Margin 63.5%
Operating Margin 29.0%
Revenue Growth YoY
Debt / Equity 0.97
AI Fundamental Assessment
P/E ratio of 31.1 (rich relative to a 15-40x range); Price-to-book of 1.8x; PEG ratio of 4.7 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 0.1%; Return on assets of 0.0%; Net margin of 0.2%; Gross margin of 0.6%; Current ratio of 13.85 (healthy short-term liquidity); Debt-to-equity of 0.97; Free cash flow margin of 1.0% (thin cash generation); Free cash flow per share is positive (1.45); Most recent quarter missed estimates by 5.3%; 3 consecutive earnings misses; EPS growth accelerating (+22.2% -> +45.5% QoQ); Analyst estimates falling over recent quarters
Key Risks
  • Risk/reward is unfavorable: 4.5% downside vs 0.1% upside.
This risk summary is generated from quantitative data signals, not qualitative opinion. All investors should conduct their own due diligence. This is not financial advice.
Get the Full SBRA Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal → Mobile
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime